October 16, 2003 – Athletes taking medication for asthma can only use inhaled formoterol, salbutamol, salmeterol or terbutaline and must declare their use to the Canadian Centre for Ethics in Sport (CCES), and if involved in international competitions, also to FIS. See specific procedures below. Coaches and athletes should ensure these forms are completed as failure to do this may result in a positive doping test for the athlete if tested. Contact Toni Scheier at CCC ascheier@sympatico.ca or 613-834-1038 for further information as required.

CCES Procedure:

For testing conducted as part of the Canadian domestic doping control program, the relevant medical authority for medication declarations is the CCES. All Canadian athletes must declare the use of: Glucocorticosteroids administered as an inhaler or as a local or intra-articular injection, or specific beta-2 agonists by inhalation only (salbutamol, salmeterol, terbutaline and formoterol) directly to the CCES prior to testing or competition in Canada. The written declaration should be made to the CCES at the time the medication was prescribed, using the Medication Declaration Form for Restricted Substances. http://www.cces.ca/pdfs/CCES-FORM-MedDec-E.pdf

Declarations for inhalers (glucocorticosteroids and the four beta-2 agonists) are valid for one year and must be renewed annually thereafter. It is the responsibility of the athlete to know when their declaration expires and to apply for renewal before this date.

A declaration for administration of local or intra-articular injections of glucocorticosteroids should be made for each single injection, except when a series of injections is planned, in which case one declaration should be submitted for the entire series.

Athletes taking medication for asthma can only use inhaled formoterol, salbutamol, salmeterol or terbutaline  and must declare their use to the Canadian Centre for Ethics in Sport (CCES), and if involved in international competitions, also to FIS. See specific procedures below. Coaches and athletes should ensure these forms are completed as failure to do this may result in a positive doping test for the athlete if tested. Contact CCES www.cces.ca  or Toni Scheier at CCC ascheier@sympatico.ca or 613-834-1038 for further information as required.

FIS Procedure: We have been informed by our FIS medical representative that all athletes using medication for ASTHMA or EXERCISE INDUCED ASTHMA must have a physician's note AND pulmonary function tests to verify the condition for all International competitions. This would be in addition to the information supplied to CCES.  The form linked below http://www.fisski.com/rulesandpublications/medicaldoping/medicalnotification form20032004.pdf must be filled out by the athlete's physician and faxed to FIS with a copy of the athlete's pulmonary function test.  Mainly this impacts athletes travelling to Europe for competitions.

Note: formoterol, salbutamol, salmeterol and terbutaline are permitted by inhalation only and require a respiratory function test with the application.  Further details are outlined in the FIS medical guide that is linked below: http://www.fisski.com/rulesandpublications/medicaldoping/medicalguide2002-20 03.pdf